Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Viremia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hodgkin Disease 1Cytomegalovirus Infections 1Communicable Diseases 1

Interventions

Valganciclovir 4Polymerase Chain Reaction 3Flow Cytometry 3Blood Specimen Collection 3Valacyclovir 2Ganciclovir 2Cell Count 2letermovir 1dolutegravir 1Zidovudine 1VCL-CB01 vaccine 1Therapeutics 1Stem Cell Transplantation 1Specimen Handling 1Ritonavir 1Peripheral Blood Stem Cell Transplantation 1Nucleosides 1Magnetic Resonance Spectroscopy 1Immunologic Techniques 1Gene-Eden-VIR 1Foscarnet 1Darunavir 1Antiviral Agents 1Acyclovir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cytomegalovirus Infections × VCL-CB01 vaccine × Clear all
NCT00285259 2024-10-21

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

Astellas Pharma Inc

Phase 2 Completed
112 enrolled
LymphoidMyeloidOther hematologic neoplasm

Communicable Diseases, Cytomegalovirus Infections, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Viremia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡